Top

R&D Center Finds Room for Condition Monitoring

May 9, 2017

Though some industries and companies lag in R&D, the pharmaceutical industry isn’t one of them. New R&D is a vital ingredient for company longevity in this industry, along with manufacturing innovation.

Recently, the pharmaceutical giant Boehringer Ingelheim built a new research center that produces small batches of active pharmaceutical ingredients (APIs) for clinical studies. The 29,000 sq ft R&D center in Biberach, Germany, employs a condition monitoring approach for inert gases being added to process tanks at variable levels of pressure.

Read More on Automation World